Olympus and Canon Unveil Aplio i800 EUS Premium Ultrasound System in the U.S.
May 4, 2026 · News Release

Olympus Corporation and Canon Medical Systems USA have jointly announced the launch of the Aplio i800 EUS premium ultrasound system in the United States. This advanced system, developed by Canon Inc. and distributed by Olympus, is specifically engineered for gastrointestinal and pulmonary endoscopic applications across the U.S. territories, including Puerto Rico and Bermuda.
The introduction of the Aplio i800 EUS system represents a significant advancement in endoscopic ultrasound (EUS) imaging technology, designed to enhance clinical evaluation capabilities in a variety of gastrointestinal procedures. This system incorporates cutting-edge ultrasound imaging processing to support high-quality visualizations, aiding clinical decision-making.
The rising incidence of liver and pancreatic diseases in the U.S. underscores the importance of advanced EUS technologies in modern clinical practice. These technologies assist clinicians in detecting conditions more promptly, potentially mitigating the necessity for more invasive diagnostic methods and supporting a more efficient, patient-focused approach to care.
The Aplio i800 EUS system provides detailed visualization and quantitative assessment capabilities, allowing for comprehensive evaluations within a single EUS-guided workflow. Miquel Àngel García, Executive Vice President and General Manager for Gastrointestinal Solutions at Olympus Corporation, emphasized the technological advancements, stating, “The Aplio i800 EUS system elevates the capabilities of our ultrasound portfolio to support clinicians in achieving improved efficiency and more confident diagnoses.”
John Serovich, Vice President of the Ultrasound/X-ray Business Unit at Canon Medical Systems USA, highlighted the collaboration with Olympus: "Partnering with Olympus marks an exciting step forward as we work together to elevate the future of EUS."
The Aplio i800 EUS system is equipped with validated imaging tools such as Shear Wave Elastography and Attenuation Imaging, enhancing liver assessment capabilities by providing metrics related to hepatic stiffness and tissue composition. Dr. Marvin Ryou, MD, Director of Endoscopic Innovation at Brigham and Women's Hospital in Boston, commented on the system's capabilities, noting that it supports a streamlined, endohepatology-driven diagnostic workflow.





